The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia

Background: Hyperuricemia has been associated with the development of high blood pressure (BP). We studied the effects of allopurinol therapy in hyperuricemic hemodialysis (HD) patients with high BP. Materials and Methods: This single-blind, randomized cross-over clinical study involved 55 HD patien...

Full description

Bibliographic Details
Main Authors: Mojgan Jalalzadeh, Zeinalabedin Nurcheshmeh, Ramin Mohammadi, Nouraddin Mousavinasab, Mohammad Hassan Ghadiani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2012;volume=17;issue=11;spage=1039;epage=1046;aulast=Jalalzadeh
_version_ 1811302479652978688
author Mojgan Jalalzadeh
Zeinalabedin Nurcheshmeh
Ramin Mohammadi
Nouraddin Mousavinasab
Mohammad Hassan Ghadiani
author_facet Mojgan Jalalzadeh
Zeinalabedin Nurcheshmeh
Ramin Mohammadi
Nouraddin Mousavinasab
Mohammad Hassan Ghadiani
author_sort Mojgan Jalalzadeh
collection DOAJ
description Background: Hyperuricemia has been associated with the development of high blood pressure (BP). We studied the effects of allopurinol therapy in hyperuricemic hemodialysis (HD) patients with high BP. Materials and Methods: This single-blind, randomized cross-over clinical study involved 55 HD patients with serum uric acid level > 6.5 (men) and > 5.5 mg/dL (women). They were randomly divided in two groups, each of which went through two phases. Group-1 in phase-1 received 100 mg/day orally of allopurinol for three months; while Group-2 was given whatever medication they received prior to the study. After two months of washing period, the groups were crossed-over. The BP levels were measured before and after HD during the eight months study period. Results: Fifty-three patients completed the study (33 men and 20 women, with mean age of 55.8 years). Uric acid levels decreased significantly during the12 weeks of allopurinol therapy (7.71 ± 1.53 to 5.2 ± 1.2 P < 0.005). Overall, after the 12 weeks of allopurinol therapy, systolic and diastolic BP also significantly decreased in allopurinol group, 15.8% (139 to 117, P < 0.0005) and 8.6% (81 to 74, P < .0005), respectively. There were not significant changes in body mass index, blood urea nitrogen, creatinine, albumin, cholesterol, triglyceride, hemoglobin, liver enzymes and serum electrolytes level after treatment. Patients treated with allopurinol had a significant increase in the quality of dialysis (KT/V) (P: 0.043). Conclusions: In HD patients, allopurinol treatment reduced BP. The results indicate a new potential therapeutic approach for controlling BP in HD patients.
first_indexed 2024-04-13T07:28:49Z
format Article
id doaj.art-1735693273164673958ef76ce6bee3f1
institution Directory Open Access Journal
issn 1735-1995
1735-7136
language English
last_indexed 2024-04-13T07:28:49Z
publishDate 2012-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Research in Medical Sciences
spelling doaj.art-1735693273164673958ef76ce6bee3f12022-12-22T02:56:24ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362012-01-01171110391046The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemiaMojgan JalalzadehZeinalabedin NurcheshmehRamin MohammadiNouraddin MousavinasabMohammad Hassan GhadianiBackground: Hyperuricemia has been associated with the development of high blood pressure (BP). We studied the effects of allopurinol therapy in hyperuricemic hemodialysis (HD) patients with high BP. Materials and Methods: This single-blind, randomized cross-over clinical study involved 55 HD patients with serum uric acid level > 6.5 (men) and > 5.5 mg/dL (women). They were randomly divided in two groups, each of which went through two phases. Group-1 in phase-1 received 100 mg/day orally of allopurinol for three months; while Group-2 was given whatever medication they received prior to the study. After two months of washing period, the groups were crossed-over. The BP levels were measured before and after HD during the eight months study period. Results: Fifty-three patients completed the study (33 men and 20 women, with mean age of 55.8 years). Uric acid levels decreased significantly during the12 weeks of allopurinol therapy (7.71 ± 1.53 to 5.2 ± 1.2 P < 0.005). Overall, after the 12 weeks of allopurinol therapy, systolic and diastolic BP also significantly decreased in allopurinol group, 15.8% (139 to 117, P < 0.0005) and 8.6% (81 to 74, P < .0005), respectively. There were not significant changes in body mass index, blood urea nitrogen, creatinine, albumin, cholesterol, triglyceride, hemoglobin, liver enzymes and serum electrolytes level after treatment. Patients treated with allopurinol had a significant increase in the quality of dialysis (KT/V) (P: 0.043). Conclusions: In HD patients, allopurinol treatment reduced BP. The results indicate a new potential therapeutic approach for controlling BP in HD patients.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2012;volume=17;issue=11;spage=1039;epage=1046;aulast=JalalzadehAllopurinolend stage renal diseasehigh blood pressureuric acid
spellingShingle Mojgan Jalalzadeh
Zeinalabedin Nurcheshmeh
Ramin Mohammadi
Nouraddin Mousavinasab
Mohammad Hassan Ghadiani
The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
Journal of Research in Medical Sciences
Allopurinol
end stage renal disease
high blood pressure
uric acid
title The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
title_full The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
title_fullStr The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
title_full_unstemmed The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
title_short The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
title_sort effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
topic Allopurinol
end stage renal disease
high blood pressure
uric acid
url http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2012;volume=17;issue=11;spage=1039;epage=1046;aulast=Jalalzadeh
work_keys_str_mv AT mojganjalalzadeh theeffectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia
AT zeinalabedinnurcheshmeh theeffectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia
AT raminmohammadi theeffectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia
AT nouraddinmousavinasab theeffectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia
AT mohammadhassanghadiani theeffectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia
AT mojganjalalzadeh effectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia
AT zeinalabedinnurcheshmeh effectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia
AT raminmohammadi effectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia
AT nouraddinmousavinasab effectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia
AT mohammadhassanghadiani effectofallopurinolonloweringbloodpressureinhemodialysispatientswithhyperuricemia